Abstract:Bilateral cavernous nerve injury-related erectile dysfunction (BCNI-ED) shows a limited response to type 5 phosphodiesterase inhibitors. Furthermore, lacosamide (LCM) can alleviate peripheral neuropathy. To explore whether LCM can improve the erectile response after BCNI, we randomly divided 30 young Sprague-Dawley rats into three groups ( n = 10 per group), namely, the sham operation, 0.9% normal saline-treated (BCNI + 0.9% NS), and LCM-treated BCNI (BCNI + LCM) groups. LCM was injected intraperitoneally at a dose of 90 mg/kg/day for 7 consecutive days. Erectile function was assessed by measuring the ratio of peak intracavernous pressure (ICP) to mean arterial pressure (MAP), and tissues were harvested for transmission electron microscopy, immunofluorescence, Masson’s trichrome staining, TUNEL staining, and Western blot analysis. The BCNI + 0.9% NS group showed reduced ICP/MAP ratio (0.93 ± 0.04 vs. 0.44 ± 0.05, P < 0.0001). An increased proportion of TUNEL-positive cells (0.04 ± 0.01 vs 0.87 ± 0.03, P < 0.0001) and a decreased smooth muscle/collagen ratio (0.44 ± 0.01 vs. 0.33 ± 0.01, P < 0.001) were observed in the BCNI + 0.9% NS compared with the sham group. Administration of LCM significantly restored the ICP/MAP ratio (0.44 ± 0.05 vs. 0.74 ± 0.05, P < 0.001) and decreased the proportion of TUNEL positive cells (0.87 ± 0.03 vs. 0.60 ± 0.04, P < 0.0001) in the corpus cavernosum following BCNI. The ratio of smooth muscle to collagen (0.43 ± 0.01vs. 0.33 ± 0.01, P < 0.01) and expression of α-SMA ( P < 0.0001) in the BCNI + LCM group significantly increased compared with BCNI + 0.9% NS group, indicating alleviation of fibrosis. Apoptotic markers, including Bax/Bcl-2 ( P < 0.01) and Caspase-3 ( P < 0.0001) in the BCNI + LCM group was significantly lower than that in the BCNI + 0.9% NS group. LCM treatment partially upregulated the expression of vWF and eNOS in cavernous tissue in rats subjected to BCNI ( P < 0.05). Increases in S100-β and nNOS expression in the major pelvic ganglion (MPG) were observed after LCM administration. In summary, LCM can recover erectile function in BCNI-ED rat model by suppressing corporal apoptosis and fibrosis, and protecting the cavernous nerve.

Neuroprotective effect of lycium barbarum polysaccharides after cavernous nerve crush injury in a rat model

Phenotypic modulation of corpus cavernosum smooth muscle cells in a rat model of cavernous neurectomy.

The Effect of Platelet-Rich Plasma on Cavernous Nerve Regeneration in a Rat Model

Lacosamide Alleviates Bilateral Cavernous Nerve Injury-Induced Erectile Dysfunction in the Rat Model by Ameliorating Pathological Changes in the Corpus Cavernosum

Effect of Platelet Rich Plasma on the Regeneration of Cavernous Nerve:Experiment with Rats

Acetyl‐L‐carnitine improves erectile function in bilateral cavernous nerve injury rats via promoting cavernous nerve regeneration

Changes in oxidative stress in rat penis after bilateral cavernous nerve crashed injury

Neural-like Cells from Adipose-Derived Stem Cells for Cavernous Nerve Injury in Rats

AB211. Effect of early chronic low-dose tadalafil administration on erectile dysfunction after cavernous nerve injury in the rat model

Effect of Early Continuous Low-dose Tadalafil on Erectile Dysfunction After Cavernous Nerve Injury in the Rats

A potential treatment for erectile dysfunction: Effect of platelet-rich plasma administration on axon and collagen regeneration in cavernous nerve injury

Lipopolysaccharide-preconditioned allogeneic adipose-derived stem cells improve erectile function in a rat model of bilateral cavernous nerve injury

Comparative Study of Intracavernous Pressure and Cavernous Pathology after Bilateral Cavernous Nerve Crushing and Resection in Rats

Neuroprotective effect of Hongjing I granules on erectile dysfunction in a rat model of bilateral cavernous nerve injury

[Restoration of Erectile Function by Reconstructing Cavernous Nerves with Small Intestinal Submucosa Grafts].

Erectile Function Restoration after Repair of Excised Cavernous Nerves by Autologous Vein Graft in Rats.

Effects of Intracavernous Injection of Adipose-Derived Stem Cells on Cavernous Nerve Regeneration in a Rat Model

Role of Oxidative Stress in Surgical Cavernous Nerve Injury in a Rat Model.

Curcumin slow‐release membrane promotes erectile function and penile rehabilitation in a rat model of cavernous nerve injury

Dual effect of chitosan activated platelet rich plasma (cPRP) improved erectile function after cavernous nerve injury

Cavernous Nerve Grafts Restore Erectile Function in Rats